HCPCS Level IIdrugActive
J9029
Instill adstiladrin, tx dose
BETOS: O1D
Effective: 2024-01-01
Description
Intravesical instillation, nadofaragene firadenovec-vncg, per therapeutic dose
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Adstiladrin
Manufacturer
Ferring Pharmaceuticals Inc.
HCPCS Dosage
Per Therapeutic Dose
Billing Units
1.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.